INVO Bioscience, Inc. (INVO)
NASDAQ: INVO · IEX Real-Time Price · USD
0.766
-0.068 (-8.11%)
At close: Jul 2, 2024, 4:00 PM
0.780
+0.014 (1.84%)
After-hours: Jul 2, 2024, 5:41 PM EDT
INVO Bioscience Market Cap
INVO Bioscience has a market cap or net worth of $2.92 million as of July 2, 2024. Its market cap has increased by 26.85% in one year.
Market Cap
2.92M
Enterprise Value
8.47M
1-Year Change
26.85%
Ranking
Category
Stock Price
$0.77
Market Cap Chart
Since November 16, 2020, INVO Bioscience's market cap has decreased from $15.20M to $2.92M, a decrease of -80.81%. That is a compound annual growth rate of -36.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 3.20M | -3.03% |
| Dec 29, 2023 | 3.30M | -36.54% |
| Dec 30, 2022 | 5.20M | -86.70% |
| Dec 31, 2021 | 39.10M | 162.42% |
| Dec 31, 2020 | 14.90M | -1.97% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lipella Pharmaceuticals | 3.42M |
| Heart Test Laboratories | 3.42M |
| Xylo Technologies | 3.36M |
| Avenue Therapeutics | 3.29M |
| Petros Pharmaceuticals | 3.20M |
| Phio Pharmaceuticals | 3.18M |
| ZyVersa Therapeutics | 3.14M |
| Revelation Biosciences | 3.12M |